期刊文献+

血管活性物质与超敏C反应蛋白及颈动脉病变对冠心病发病的影响因素分析 被引量:16

Correlation between Plasma Vasoactive Substances,High-sensitivity C-reactive Protein,and Carotid Artery Lesions and Coronary Heart Diseases
暂未订购
导出
摘要 目的探讨血管活性物质、超敏C反应蛋白(hsCRP)水平及颈动脉病变对冠心病发病的影响。方法住院行介入治疗的冠心病患者99例,以单纯高血压患者122例为对照,测定其血脂、血浆同型半胱氨酸(Hcy)、一氧化氮(NO)、hsCRP水平,并行颈动脉超声检查。结果冠心病患者血浆Hcy水平为(18.57±7.47)μmol/L,明显高于单纯高血压组[(14.53±10.58)μmol/L,P=0.002];hsCRP水平为(3.73±3.89)mg/L,明显高于单纯高血压组[(2.38±2.86)mg/L,P=0.008]。冠心病患者血清NO水平为(51.15±18.78)μmol/L,明显低于单纯高血压组[(70.39±41.55)μmol/L,P=0.000]。冠心病组颈动脉病变占94.1%,明显高于高血压组(P=0.000)。多元回归分析显示低TC、高Hcy、低NO、高hsCRP水平是冠心病发病的独立影响因素(P<0.05)。结论高Hcy水平、低NO水平以及颈动脉病变与冠心病发生明显相关,因此血管活性物质测定及简单、无创、重复性好的颈动脉超声有望成为观察冠状动脉病变的窗口。 Objective To investigate the influences of plasma vasoactive substances, high - sensitivity C - reactive protein (hsCRP) , and carotid artery lesions on coronary heart disease (CHD) . Methods Plasma homoeysteine (Hcy), nitric oxide (NO) , and hsCRP levels were measured in 99 hospitalized patients with coronary heart disease (CHD group) , while 122 patients with essential hypertension (EH group) were act as controls. Carotid artery ultrasound was performed. Results Serum Hcy was ( 18. 57 ±7.47) ±mol / L in CHD group, which was significantly higher than that in EH group ( 14. 53±10. 58) ±mol / L (P 〈0. O1 ) . Serum NO in CHD group [ (51.15± 18.78) ±mol/L] was significantly lower than that in EH group [ (70. 39 ±41.55)±mol/ L] (P 〈0. 001 ) . Carotid artery lesions were found in 94. 1% of patients in CHD group, which was significantly higher than that in EH group ( P 〈 0. 001 ) . Conclusion High homocysteinemia, low plasma NO, and carotid artery lesions are closely correlated with the occurrence of coronary heart disease. Vasoactive substances measurement and carotid artery ultrasound are useful tool in detecting coronary artery diseases.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第6期620-622,共3页 Chinese General Practice
关键词 冠心病 高血压 同型半胱氨酸 一氧化氮 颈动脉病变 Coronary artery disease hypertension homocysteine nitric oxide Carotid artery ultrasound
  • 相关文献

参考文献10

  • 1陈灏珠.动脉粥样硬化[M]//实用内科学.10版.北京:人民卫生出版社,1997:1218-1225.
  • 2Tanaka H, Nishlno M, Ishida M, et al. Progression of carotid atherosclerosis in Japaneas patients wiht coronary artery disease [ J] . Stroke, 1992, 23: 946-951.
  • 3Oleary DH, Polak JF, Kronmal RA, etal. Distribution and conrelates of sonographically detected carotial artery disease in the cardiovascular heahh study IJ] .Stroke, 1992, 23: 1752-1760.
  • 4Zeng XK, DAi J, Daniel G, et al. Homocysteine mediated expression and secretion of monocyte chemoattractant protein - i and Interleukm - 8 in human monocytes [J] . Circ Res, 2003, 93 (4) : 311 -320.
  • 5Zhang Q, Zeng XK, Guo JK, et al. Effects of homocysteine on murine splenic B lymphocyte proliferation and its signal transduction mechanism [J] . Cardiovasc Res, 2001, 52 (2) : 328 -336.
  • 6Zhang Q, Zeng XK, Guo JK, et al. Oxidant stress mechanism of homocysteine potentiating Con A - induced proliferation in murine splenic T lymphocytes [J]. Cardiovasc Res, 2002, 53 (4): 1035-1042.
  • 7Wang G, Dai J, Mao J, et al. Folic acid reverses hyperresponsiveness of LPS - induced chemokine secretion from monocytes in paitients with hyperhomocysteinemia [J] . Atherosclerosis, 2005, 179 (2): 395- 402.
  • 8张宝娓,汪波,姚兴海,张永刚,曹军,张钧华,唐朝枢.动脉粥样硬化家兔主动脉壁与红细胞L精氨酸/一氧化氮系统变化[J].中华心血管病杂志,2002,30(5):302-304. 被引量:19
  • 9Schalchar C, Cotter G, Reisin L, et al. The dual endot helin recep2tor antagonist Lezosentan acutely improves hemodynamie pavmetens in patient with advanced heart failure [ J] . Circulation, 2001, 103: 973- 980.
  • 10Ortolani P, Marzoeehi A, Marrozzini C, et al. Clinical relevance of homocysteine levels in patient s receiving coronary stenting for unstable angina [J] . Hal Heart J, 2004, 5 (3) : 189 -196.

二级参考文献2

共引文献18

同被引文献153

引证文献16

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部